These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 947189)

  • 1. [Clinical questions on bioavailability and proff of efficacy (author's transl)].
    Gillmann H
    Arzneimittelforschung; 1976; 26(1A):103-4. PubMed ID: 947189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
    Schnieders B
    Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
    Lesne M
    J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bioavailability of different brands of phenoxymethylpenicillin (author's transl)].
    Simon C; Malerczyk V; Grothkopp J
    Med Klin; 1975 Oct; 70(41):1637-40. PubMed ID: 810652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability studies and the clinical pharmacologist: correlation of drug distribution with clinical effects.
    Ogilvie RI
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):349-54. PubMed ID: 1099026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical problems of optimum bioavailability, in particular in cytostatic therapy (author's transl)].
    Gross R; Hirschmann WD
    Arzneimittelforschung; 1976; 26(1A):130-5. PubMed ID: 947192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological availability].
    Weber E; Gundert-Remy U
    Arzneimittelforschung; 1975 Jul; 25(7a):1158-62. PubMed ID: 1242346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical problems in interpreting comparative bioavailability trials.
    Westlake WJ
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):342-5. PubMed ID: 1099025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
    Cabana BE
    Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bioavailability data by practitioners. I: pitfalls in interpreting the data.
    Schumacher GE
    Am J Hosp Pharm; 1975 Aug; 32(8):639-42. PubMed ID: 1146833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioavailability or Bioavailments? (AUTHOR'S TRANSL)].
    Dost FH
    Schweiz Rundsch Med Prax; 1974 Oct; 63(42):1251-2. PubMed ID: 4438242
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bioavailability of drugs. Complexity of biological membranes and methods of "in vitro" simulation (author's transl)].
    Galer J; Rondelet J
    J Pharm Belg; 1976; 31(5):451-66. PubMed ID: 993967
    [No Abstract]   [Full Text] [Related]  

  • 16. The general problem of drug bioavailability and its assessment in man.
    Smith RN
    Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of bioavailability to the pharmacist.
    Canada AT
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):346-8. PubMed ID: 1158541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bioavailability and its significance in pharmacotherapy].
    Wiela-Hojeńska A; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2003 Jan; 14(79):89-93. PubMed ID: 12712840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The danger of fixed drug combinations.
    Herxheimer H
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):70-3. PubMed ID: 1165144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biopharmaceutics studies of acetylsalicylic acid: use of a pharmacological test for bioavailability study of different acetylsalicylic acid dosage forms (author's transl)].
    Sado PA; Linée P; Le Verge R; Devissaguet JP
    J Pharm Belg; 1977; 32(6):549-60. PubMed ID: 612698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.